Literature DB >> 32488216

The predictive value of repeated blood pressure measurements in childhood for cardiovascular risk in adults: the Hanzhong Adolescent Hypertension Study.

Yue-Yuan Liao1,2, Qiong Ma1,2, Chao Chu1,2, Yang Wang1,2, Wen-Ling Zheng1,2, Jia-Wen Hu1,2, Yu Yan1,2, Ke-Ke Wang1,2, Yue Yuan1,2, Chen Chen1,2, Jian-Jun Mu3,4.   

Abstract

There is currently a lack of strong evidence linking childhood elevated blood pressure to long-term cardiovascular risk in adulthood. Repeated observations of abnormal blood pressure in childhood may enhance the prediction of cardiovascular risk in adulthood compared with a single observation. The study included 1738 individuals in rural areas of Hanzhong City, Shaanxi, who had been followed for 30 years since baseline (1987, at which time participants were aged 6-15 years). According to four independent measurements of blood pressure in 1987, 1989, 1992, and 1995, childhood elevated blood pressure was defined as 2 in-person examinations with blood pressure values above the 90th percentile. Arterial stiffness and left ventricular hypertrophy in adulthood were assessed by brachial-ankle pulse wave velocity and the Cornell product index, respectively. Childhood elevated blood pressure was associated with an increased risk of adult hypertension (OR, 2.01; 95% CI, 1.53-2.65), arterial stiffness (OR, 1.69; 95% CI, 1.32-2.16) and left ventricular hypertrophy (OR, 1.86; 95% CI, 1.13-3.05) (all P < 0.05). Cardiovascular risk in adults increased with increasing childhood blood pressure levels. In addition, two abnormal childhood blood pressure observations predicted an increased likelihood of hypertension in adulthood (0.77 for 2 versus 0.70 for 1 observation, P < 0.001). Our study provides strong evidence that elevated blood pressure in childhood predicts cardiovascular risk in adults. The prediction was enhanced by two observations of abnormal blood pressure in childhood compared with a single measurement. We emphasize the importance of childhood blood pressure monitoring and control in the prevention of cardiovascular diseases.

Entities:  

Keywords:  Adulthood; Blood pressure; Cardiovascular risk; Childhood; Cohort study.

Year:  2020        PMID: 32488216     DOI: 10.1038/s41440-020-0480-7

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  34 in total

1.  Regression of left ventricular hypertrophy in children with antihypertensive therapy.

Authors:  Prema Ramaswamy; Irene D Lytrivi; Chikku Paul; Mary Golden; Juan C Kupferman
Journal:  Pediatr Nephrol       Date:  2006-09-06       Impact factor: 3.714

2.  Screening for primary hypertension in children and adolescents: U.S. Preventive Services Task Force recommendation statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2013-11-05       Impact factor: 25.391

3.  Essential hypertension predicted by tracking of elevated blood pressure from childhood to adulthood: the Bogalusa Heart Study.

Authors:  W Bao; S A Threefoot; S R Srinivasan; G S Berenson
Journal:  Am J Hypertens       Date:  1995-07       Impact factor: 2.689

4.  Childhood risk factors for high adult blood pressure: the Muscatine Study.

Authors:  R M Lauer; W R Clarke
Journal:  Pediatrics       Date:  1989-10       Impact factor: 7.124

5.  Influence of age on associations between childhood risk factors and carotid intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study, the Childhood Determinants of Adult Health Study, the Bogalusa Heart Study, and the Muscatine Study for the International Childhood Cardiovascular Cohort (i3C) Consortium.

Authors:  Markus Juonala; Costan G Magnussen; Alison Venn; Terence Dwyer; Trudy L Burns; Patricia H Davis; Wei Chen; Sathanur R Srinivasan; Stephen R Daniels; Mika Kähönen; Tomi Laitinen; Leena Taittonen; Gerald S Berenson; Jorma S A Viikari; Olli T Raitakari
Journal:  Circulation       Date:  2010-11-29       Impact factor: 29.690

6.  Childhood physical, environmental, and genetic predictors of adult hypertension: the cardiovascular risk in young Finns study.

Authors:  Jonna Juhola; Mervi Oikonen; Costan G Magnussen; Vera Mikkilä; Niina Siitonen; Eero Jokinen; Tomi Laitinen; Peter Würtz; Samuel S Gidding; Leena Taittonen; Ilkka Seppälä; Antti Jula; Mika Kähönen; Nina Hutri-Kähönen; Terho Lehtimäki; Jorma S A Viikari; Markus Juonala; Olli T Raitakari
Journal:  Circulation       Date:  2012-06-20       Impact factor: 29.690

7.  Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease.

Authors:  Chi-yuan Hsu; Charles E McCulloch; Jeanne Darbinian; Alan S Go; Carlos Iribarren
Journal:  Arch Intern Med       Date:  2005-04-25

8.  Association between blood pressure level and the risk of myocardial infarction, stroke, and total mortality: the cardiovascular health study.

Authors:  B M Psaty; C D Furberg; L H Kuller; M Cushman; P J Savage; D Levine; D H O'Leary; R N Bryan; M Anderson; T Lumley
Journal:  Arch Intern Med       Date:  2001-05-14

9.  Regression of left-ventricular hypertrophy in children and adolescents with hypertension during ramipril monotherapy.

Authors:  Tomás Seeman; Jirí Gilík; Karel Vondrák; Eva Simková; Hana Flögelová; Marie Hladíková; Jan Janda
Journal:  Am J Hypertens       Date:  2007-09       Impact factor: 2.689

10.  High blood pressure and its relationship to adiposity in a school-aged population: body mass index vs waist circumference.

Authors:  William Rodrigues Tebar; Raphael Mendes Ritti-Dias; Breno Quintella Farah; Edner Fernando Zanuto; Luiz Carlos Marques Vanderlei; Diego Giulliano Destro Christofaro
Journal:  Hypertens Res       Date:  2017-10-26       Impact factor: 3.872

View more
  6 in total

1.  Predictive Value of Galectin-3 and Brachial-Ankle Pulse Wave Velocity for Coronary Artery Calcification in Coronary Arteriography Patients.

Authors:  Lei Tian; Fenghua Ding; Ruiyan Zhang
Journal:  Int J Clin Pract       Date:  2022-05-16       Impact factor: 3.149

2.  Association of Uric Acid in Serum and Urine with Arterial Stiffness: Hanzhong Adolescent Hypertension Study.

Authors:  Yang Wang; Xiao-Yu Zhang; Wei-Hua Gao; Ming-Fei Du; Chao Chu; Dan Wang; Chen Chen; Yue Yuan; Qiong Ma; Yue-Yuan Liao; Yu Yan; Ke-Ke Wang; Jie Zhang; Ke Gao; Chun-Hua Li; Hao Li; Qiong Ma; Jia-Wen Hu; Ting Zou; Yue Sun; Min Li; Hao-Wei Zhou; Hao Jia; Jian-Jun Mu
Journal:  Dis Markers       Date:  2020-07-16       Impact factor: 3.434

3.  Association of pulsatile stress in childhood with subclinical renal damage in adults: A 30-year prospective cohort study.

Authors:  Yueyuan Liao; Chao Chu; Yang Wang; Wenling Zheng; Qiong Ma; Jiawen Hu; Yu Yan; Jun Yang; Ruihai Yang; Keke Wang; Yue Yuan; Chen Chen; Yue Sun; Yuliang Wu; Jianjun Mu
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-09-08       Impact factor: 3.738

4.  Early life body mass index trajectories and albuminuria in midlife: A 30-year prospective cohort study.

Authors:  Yang Wang; Fei Li; Chao Chu; Xi Zhang; Xiao-Yu Zhang; Yue-Yuan Liao; Ming-Fei Du; Ting Zou; Qiong Ma; Chen Chen; Dan Wang; Ke-Ke Wang; Yu Yan; Yue Sun; Gui-Lin Hu; Hao Jia; Hao Li; Ze-Jiaxin Niu; Rui-Chen Yan; Zi-Yue Man; Lan Wang; Wen-Jing Luo; Jie Zhang; Chun-Hua Li; Wan-Hong Lu; John Chang; Robert Safirstein; Yao Lu; Jian-Jun Mu
Journal:  EClinicalMedicine       Date:  2022-04-28

5.  Isolated diastolic hypertension in childhood and risk of adult subclinical target organ damage: a 30-year prospective cohort study.

Authors:  Yueyuan Liao; Chao Chu; Yang Wang; Wenling Zheng; Qiong Ma; Jiawen Hu; Yu Yan; Jun Yang; Ruihai Yang; Keke Wang; Yue Yuan; Chen Chen; Yue Sun; Jianjun Mu
Journal:  J Hypertens       Date:  2022-06-21       Impact factor: 4.776

6.  Blood pressure and long-term subclinical cardiovascular outcomes in low-risk young adults: Insights from Hanzhong adolescent hypertension cohort.

Authors:  Yu Yan; Qiong Ma; Yueyuan Liao; Chen Chen; Jiawen Hu; Wenling Zheng; Chao Chu; Keke Wang; Yue Sun; Ting Zou; Yang Wang; Jianjun Mu
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-02-19       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.